RMS utilizes patented technology to grow iPSC-derived pancreatic cells for dual use as research tools and direct cell therapeutic targeting diabetes
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free